A study to assess the ability of certain indices to predict the failure of high flow nasal cannula oxygen therapy when used for respiratory failure due to low oxygen levels.
Not Applicable
- Conditions
- Health Condition 1: J00-J99- Diseases of the respiratory system
- Registration Number
- CTRI/2023/09/057318
- Lead Sponsor
- Dr Saurabh Taneja
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients above 18 years of age.
2. Both males and females.
Exclusion Criteria
1. Patients with an history of asthma or an exacerbation of chronic obstructive pulmonary
disease (COPD).
2. Patients on domiciliary oxygen therapy for more than 7 days.
3. Absence of commitment to pursue full life support measures (Do-not-intubate or Do-not-
resuscitate orders).
4. Glasgow coma scale < 12.
5. Epistaxis, facial trauma, or recent nasal/facial surgery.
6. Refusal to consent for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Failure of HFNC therapy as evidenced by the need of upgradation of respiratory support <br/ ><br>to mechanical ventilation noninvasive or invasiveTimepoint: At 6 & 12 hours after initiation of HFNC
- Secondary Outcome Measures
Name Time Method ILTimepoint: 0